Skin patch for kids with peanut allergy shows promise
But trial results failed to meet a statistical element of the primary outcome, say researchers
25th February 2019
By Kemal Atlay
More than one-third of children with peanut allergy successfully built up their tolerance to peanut protein after treatment with an immunotherapy skin patch, a study with Australian participants has shown.
However, the results failed to meet a statistical element of the primary outcome set by the US Food and Drug Administration, leaving clinicians to decide for themselves if the peanut-patch treatment has promise.
In a phase III trial conducted across 31 international sites, including three in Australia, 356 peanut-allergic children aged between four and 11, with no history